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reamble
ver the past decade, there has been an increasing aware-
ess that the quality of medical care delivered in the United
tates is variable. In its seminal document dedicated to
haracterizing deficiencies in delivering effective, timely,
afe, equitable, efficient, and patient-centered medical care,
he Institute of Medicine described a quality “chasm” (1).
ecognition of the magnitude of the gap between the care
hat is delivered and the care that ought to be provided has
able 1. ACCF/AHA Performance Measure Sets
Topic
Original
Publication Date
hronic heart failure (2) 2005 AC
AC
hronic stable coronary artery disease (3) 2005 AC
ypertension (4) 2005 AC
T-elevation and non–ST-elevation myocardial
infarction (5)
2006 AC
ardiac rehabilitation (7) 2007 AA
trial fibrillation (8) 2008 AC
rimary prevention of cardiovascular disease (9) 2009 AC
eripheral artery disease 2010* AC
ercutaneous coronary intervention 2011* AC
Planned publication date.
AACVPR indicates American Association of Cardiovascular and Pulmonary Rehabilitation; ACmerican Medical Association—Physician Consortium for Performance Improvement; SCAI, Society for C
ascular Medicine; SVN, Society for Vascular Nursing; and SVS, Society for Vascular Surgery.timulated interest in the development of measures of
uality of care and the use of such measures for the purposes
f quality improvement and accountability.
Consistent with this national focus on healthcare quality, the
merican College of Cardiology Foundation (ACCF) and the
merican Heart Association (AHA) have taken a leadership
ole in developing measures of the quality of care for cardio-
ascular disease (CVD) in several clinical areas (Table 1). The
CCF/AHA Task Force on Performance Measures was
ormed in February 2000 and was charged with identifying the
linical topics appropriate for the development of performance
easures and assembling writing committees composed of
linical and methodological experts. When appropriate, these
ommittees include representatives from other organizations
ith an interest in the clinical topic under consideration. The
ommittees are informed about the methodology of perfor-
ance measure development and are instructed to construct
easures for use both prospectively and retrospectively, rely
pon easily documented clinical criteria, and where appropri-
te, incorporate administrative data. The data elements re-
uired for the performance measures are linked to existing
CCF/AHA clinical data standards to encourage uniform
easurements of cardiovascular care. The writing commit-
ees are also instructed to evaluate the extent to which
xisting nationally recognized performance measures con-
orm to the attributes of performance measures described by
he ACCF/AHA and to strive to create measures aligned
ith acceptable existing measures when this is feasible.
The initial measure sets published by the ACCF/AHA
ocused primarily on processes of medical care or actions taken
y healthcare providers, such as the prescription of a medica-
ion for a condition. These process measures are founded on
he strongest recommendations contained in the ACCF/AHA
linical practice guidelines, delineating actions taken by clini-
ians in the care of patients, such as the prescription of a
articular drug for a specific condition. Specifically, the writing
ommittees consider as candidates for measures those processes
Partnering Organizations Status
—Inpatient measures
/PCPI—Outpatient measures
Currently undergoing update
Currently undergoing update
/PCPI Currently undergoing update
/PCPI Currently undergoing update
Updated 2008 (6)
ACC/AHA Updated 2010 (referral measures only)
/PCPI
A
A/ACR/SCAI/SIR/SVM/ SVN/SVS Under development
A/SCAI/PCPI/NCQA Under development
rican College of Radiology; NCQA, National Committee for Quality Assurance; PCPI indicatesC/AHA
C/AHA
C/AHA
C/AHA
C/AHA
CVPR/
C/AHA
CF/AH
CF/AH
CF/AH
R, Ame
ardiac Angiography and Interventions; SIR, Society for Interventional Radiology; SVM, Society for
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September 28, 2010:1159–67 Cardiac Rehabilitation Performance Measures: Updatef care that are recommended by the guidelines either as Class
, which identifies procedures/treatments that should be ad-
inistered, or Class III, which identifies procedures/
reatments that should not be administered (Table 2). Class II
ecommendations are not considered as candidates for perfor-
ance measures. The methodology guiding the translation of
uideline recommendations into process measures has been
xplicitly delineated by the ACCF/AHA, providing guidance
o the writing committees (10).
Although they possess several strengths, processes of care are
imited as the sole measures of quality. Thus, current ACCF/
able 2. Applying Classification of Recommendations and Leve
Data available from clinical trials or registries about the usefulness/efficacy in different subpopu
ailure, and prior aspirin use. A recommendation with Level of Evidence B or C does not imply th
end themselves to clinical trials. Even though randomized trials are not available, there may be
ffectiveness recommendations (Class I and IIa; Level of Evidence A and B only), studies that s
eing evaluated.HA performance measures writing committees are instructed wo consider measures of structures of care, outcomes, and
fficiency as complements to process measures. In developing
uch measures, the committees are guided by methodology
stablished by the ACCF/AHA (11). Although implementa-
ion of measures of outcomes and efficiency is currently not as
ell established as that of process measures, it is expected that
uch measures will become more pervasive over time.
Although the focus of the performance measures writing
ommittees is on measures intended for quality improvement
fforts, other organizations may use these measures for external
eview or public reporting of provider performance. Therefore, it is
vidence
, such as gender, age, history of diabetes, history of prior myocardial infarction, history of heart
ecommendation is weak. Many important clinical questions addressed in the guidelines do not
clear clinical consensus that a particular test or therapy is useful or effective. †For comparative
the use of comparator verbs should involve direct comparisons of the treatments or strategiesl of E
lations
at the r
a veryithin the scope of the writing committee’s task to comment,
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xternal reporting for a particular CVD state or patient popula-
ion. Thus, the metrics contained within this document are
ategorized as either performance measures or test measures. Perfor-
ance measures are those metrics that the committee designates
s appropriate for use for both quality improvement and external
eporting. In contrast, test measures are those appropriate for
he purposes of quality improvement but not for external
eporting until further validation and testing are performed.
All measures have limitations and pose challenges to imple-
entation that could result in unintended consequences when
sed for accountability. The implementation of measures for
urposes other than quality improvement requires field testing
o address issues related but not limited to sample size,
requency of use of an intervention, comparability, and audit
equirements. The manner in which these issues are addressed
s dependent on several factors, including the method of data
ollection, performance attribution, baseline performance rates,
ncentives, and public reporting methods. The ACCF/AHA
ncourages those interested in implementing these measures
or purposes beyond quality improvement to work with the
CCF/AHA to consider these complex issues in pilot imple-
entation projects, to assess limitations and confounding
actors, and to guide refinements of the measures to enhance
heir utility for these additional purposes.
By facilitating measurements of cardiovascular healthcare qual-
ty, ACCF/AHA performance measurement sets may serve as
ehicles to accelerate appropriate translation of scientific evidence
nto clinical practice. These documents are intended to provide
ractitioners and institutions that deliver care with tools to
easure the quality of their care and identify opportunities for
mprovement. It is our hope that application of these perfor-
ance measures will provide a mechanism through which the
uality of medical care can be measured and improved.
Frederick A. Masoudi, MD, MSPH, FACC, FAHA
Chair, ACCF/AHA Task Force on Performance Measures
. Update of Performance Measures for
eferral to Cardiac Rehabilitation
.1. Background
he AACVPR/ACC/AHA 2007 Performance Measures on
ardiac Rehabilitation for Referral to and Delivery of Cardiac
ehabilitation/Secondary Prevention Services were published
n October 2007 (7). This document updates the 2 measures
hat articulate the opportunities to improve referrals to outpa-
ient Cardiac Rehabilitation that were embodied in Measure
et A from that 2007 paper (Appendix A in [7]). Measure A-1
Cardiac Rehabilitation Patient Referral From an Inpatient
etting) and measure A-2 (Cardiac Rehabilitation Patient
eferral From an Outpatient Setting) have been revised to
larify several aspects of the measures and to facilitate their
mplementation. The updated measures (Appendix B) have
een revised as described in the following text. The measures ineasure Set B from the 2007 paper related to the structure and
rocesses of care for cardiac rehabilitation programs remain
nchanged and are not included in this update.
.2. Measure A-1. Cardiac Rehabilitation Patient
eferral From an Inpatient Setting
umerator Exclusion Criteria:
• “Patient-oriented barriers” was revised to “patient-
oriented factors,” and the example provided was
changed. Patient refusal, which was listed as an exam-
ple in the 2007 paper, should not be considered a
reason not to provide a referral. Whether the patient
chooses to act upon the referral or not is beyond the
provider’s control. The example provided in this up-
date clarifies that patients discharged to a nursing care
facility for long-term care can be excluded.
• “Provider-oriented barriers” was revised to “medical fac-
tors,” and the examples provided were changed. The
2007 measures listed “patient deemed to have a high-risk
condition or a contraindication to exercise” as an exam-
ple. This was revised to specify “medically unstable, life-
threatening condition” as an example of an appropriate
medical exclusion. The rationale reflects the capacity of
cardiac rehabilitation programs to modify their program to
the medical needs of individual patients and that, other than
life-threatening conditions, there are no a priori reasons
to presume that a patient might not be able to participate
in a rehabilitation and secondary prevention program.
• “Health care system barriers” was revised to “health-
care system factors,” and the examples provided were
changed. “Financial barriers” was deleted and “lack of
CR programs near a patient’s home” was clarified to
specify no cardiac rehabilitation program available
within 60 minutes of travel time from the patient’s home.
enominator:
note was added to clarify that patients with a qualifying event
ho are to be discharged for a short-term stay in an inpatient
edical rehabilitation facility are still expected to be referred to an
utpatient cardiac rehabilitation program by the inpatient team
uring the index hospitalization. This referral should be reinforced
y the care team at the medical rehabilitation facility.
orresponding Guidelines and Clinical Recommendations:
he recommendations in this section were updated to
eflect the most recent iterations of the guidelines cited.
.3. Measure A-2. Cardiac Rehabilitation Patient
eferral From an Outpatient Setting
umerator:
• The note describing what constitutes a referral has
been expanded to clarify that standards of practice for
cardiac rehabilitation programs require care coordina-
tion communications to be sent to the referring pro-
vider, including any issues regarding treatment
changes, adverse treatment responses, or new non-
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questions, etc.) that need attention by the referring
provider. These communications also include a progress
report once the patient has completed the program.
• Exclusion criteria: The same revisions made to the
patient, medical, and health system factors described for
Measure A-1 in Section 1.2 were made to this measure.
enominator:
he denominator statement was clarified to specify that
nly patients who have had a qualifying event/diagnosis
uring the previous 12 months and have not participated in
n outpatient cardiac rehabilitation program since the qual-
fying event/diagnosis should be included.
ttribution/Aggregation:
his section was added to clarify that 1) the measure should be
eported by the clinician who provides the primary
ardiovascular-related care for the patient (In general, this
ould be the patient’s cardiologist, but in some cases it might
e a family physician, internist, nurse practitioner, or other
ealthcare provider.); and 2) the level of aggregation (clinician
ersus practice) will depend upon the availability of adequate
ample sizes to provide stable estimates of performance.
.4. Administrative Codes to Identify
enominator-Eligible Populations
o facilitate implementation of these measures in a variety of
ystems, we have included administrative codes that may be
seful in identifying the population of patients who are eligible
or inclusion in the denominator for each of the updated
easures. See the online data supplement for details.
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OR REFERRAL TO CARDIAC REHABILITATION/SECONDARY PREVENTION SERVICES
Performance Measure A-1
A-1. Cardiac Rehabilitation Patient Referral From an Inpatient Setting
All patients hospitalized with a primary diagnosis of an acute myocardial infarction (MI) or chronic stable angina (CSA), or who during hospitalization have
undergone coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation
are to be referred to an early outpatient cardiac rehabilitation/secondary prevention (CR) program.
umerator Number of eligible patients with a qualifying event/diagnosis who have been referred to an outpatient CR program prior to hospital
discharge or have a documented medical or patient-centered reason why such a referral was not made.
(Note: The program may include a traditional CR program based on face-to-face interactions and training sessions or may include
other options such as home-based approaches. If alternative CR approaches are used, they should be designed to meet appropriate
safety standards.)
A referral is defined as an official communication between the healthcare provider and the patient to recommend and carry out a
referral order to an early outpatient CR program. This includes the provision of all necessary information to the patient that will
allow the patient to enroll in an early outpatient CR program. This also includes a written or electronic communication between the
healthcare provider or healthcare system and the cardiac rehabilitation program that includes the patient’s enrollment information
for the program. A hospital discharge summary or office note may potentially be formatted to include the necessary patient
information to communicate to the CR program (e.g., the patient’s cardiovascular history, testing, and treatments). All
communications must maintain appropriate confidentiality as outlined by the 1996 Health Insurance Portability and Accountability
Act (HIPAA).
Exclusion criteria:
● Patient factors (e.g., patient to be discharged to a nursing care facility for long-term care).
● Medical factors (e.g., patient deemed by provider to have a medically unstable, life-threatening condition).
● Health care system factors (e.g., no cardiac rehabilitation program available within 60 minutes of travel time from the patient’s
home).
enominator Number of hospitalized patients in the reporting period hospitalized with a qualifying event/diagnosis who do not meet any of the
exclusion criteria mentioned in the Numerator section.
(Note: Patients with a qualifying event who are to be discharged for a short-term stay in an inpatient medical rehabilitation facility
are still expected to be referred to an outpatient cardiac rehabilitation program by the in-patient team during the index
hospitalization. This referral should be reinforced by the care team at the medical rehabilitation facility.)
eriod of Assessment Inpatient hospitalization.
ethod of Reporting Proportion of healthcare system’s patients with a qualifying event/diagnosis who had documentation of their referral to an
outpatient CR program.
ources of Data Administrative data and/or medical records.
Rationale
key component to outpatient CR program utilization is the appropriate and timely referral of patients. Generally, the most important time for this referral to take
lace is while the patient is hospitalized for a qualifying event/diagnosis (MI, CSA, CABG, PCI, cardiac valve surgery, or cardiac transplantation).
his performance measure has been developed to help healthcare systems implement effective steps in their systems of care that will optimize the appropriate
eferral of a patient to an outpatient CR program.
his measure is designed to serve as a stand-alone measure or, preferably, to be included within other performance measurement sets that involve disease states
r other conditions for which CR services have been found to be appropriate and beneficial (e.g., following MI, CABG surgery). This performance measure is provided
n a format that is meant to allow easy and flexible inclusion into such performance measurement sets.
ffective referral of appropriate inpatients to an outpatient CR program is the responsibility of the healthcare team within a healthcare system that is primarily
esponsible for providing cardiovascular care to the patient during the hospitalization.
Corresponding Guidelines and Clinical Recommendations
CC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery (12).
lass I
ardiac rehabilitation should be offered to all eligible patients after CABG (Level of Evidence: B).
CC/AHA 2007 Update of the Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (13).
lass I
dvising medically supervised programs (cardiac rehabilitation) for high-risk patients (e.g., recent acute coronary syndrome or revascularization, heart failure) is
ecommended (Level of Evidence: B).
CC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction (14).
lass I
ardiac rehabilitation/secondary prevention programs are recommended for patients with unstable angina/non–ST-segment elevation MI, particularly those with
ultiple modifiable risk factors and/or those moderate- to high-risk patients in whom supervised exercise training is particularly warranted (Level of Evidence: B).
ardiac rehabilitation/secondary prevention programs, when available, are recommended for patients with unstable angina/non–ST-segment elevation MI,
articularly those with multiple modifiable risk factors and those moderate- to high-risk patients in whom supervised or monitored exercise training is warranted
Level of Evidence: B).
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Cardiac Rehabilitation Performance Measures: Update September 28, 2010:1159–67CC/AHA 2007 Chronic Angina Focused Update of the Guidelines for the Management of Patients With Chronic Stable Angina (15).
lass I
edically supervised programs (cardiac rehabilitation) are recommended for at-risk patients (e.g., recent acute coronary syndrome or revascularization, heart
ailure) (Level of Evidence: B).
CC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult (16).
lass I
xercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of heart failure and
educed left ventricular ejection fraction (LVEF) (Level of Evidence: B).
HA Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update (17).
lass I
comprehensive risk-reduction regimen, such as cardiovascular or stroke rehabilitation or a physician-guided home- or community-based exercise training program,
hould be recommended to women with a recent acute coronary syndrome or coronary intervention, new-onset or chronic angina, recent cerebrovascular event,
eripheral arterial disease (Level of Evidence: A), or current/prior symptoms of heart failure and an LVEF 40% (Level of Evidence: B).
CC/AHA/SCAI 2007 Focused Update of the Guidelines for Percutaneous Coronary Intervention (18).
lass I
dvising medically supervised programs (cardiac rehabilitation) for high-risk patients (e.g., recent acute coronary syndrome or revascularization, heart failure) is
ecommended (Level of Evidence: B).
Challenges to Implementation
dentification of all eligible patients in an inpatient setting will require that a timely, accurate, and effective system be in place. Communication of referral
nformation by the inpatient hospital service team to the outpatient CR program represents a potential challenge to the implementation of this performance
easure. However, this task is generally performed by an inpatient cardiovascular care team member, such as an inpatient CR team member or a hospital
ischarge planning team member.
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A-2. Cardiac Rehabilitation Patient Referral From an Outpatient Setting
All patients evaluated in an outpatient setting who within the past 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass
graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic stable angina
(CSA) and have not already participated in an early outpatient cardiac rehabilitation/secondary prevention (CR) program
for the qualifying event/diagnosis are to be referred to such a program.
umerator Number of patients in an outpatient clinical practice who have had a qualifying event/diagnosis during the previous 12 months, who
have been referred to an outpatient CR program.
(Note: The program may include a traditional CR program based on face-to-face interactions and training sessions or other options
that include home-based approaches. If alternative CR approaches are used, they should be designed to meet appropriate safety
standards.)
A referral is defined as an official communication between the healthcare provider and the patient to recommend and carry out a
referral order to an outpatient CR program. This includes the provision of all necessary information to the patient that will allow the
patient to enroll in an outpatient CR program. This also includes a written or electronic communication between the healthcare
provider or healthcare system and the cardiac rehabilitation program that includes the patient’s enrollment information for the
program. A hospital discharge summary or office note may potentially be formatted to include the necessary patient information to
communicate to the CR program (e.g., the patient’s cardiovascular history, testing, and treatments). According to standards of
practice for cardiac rehabilitation programs, care coordination communications are sent to the referring provider, including any
issues regarding treatment changes, adverse treatment responses, or new nonemergency condition (new symptoms, patient care
questions, etc.) that need attention by the referring provider. These communications also include a progress report once the patient
has completed the program. All communications must maintain an appropriate level of confidentiality as outlined by the 1996
Health Insurance Portability and Accountability Act (HIPAA).
Exclusion criteria:
● Patient factors (e.g., patient resides in a long-term nursing care facility).
● Medical factors (e.g., patient deemed by provider to have a medically unstable, life-threatening condition).
● Health care system factors (e.g., no cardiac rehabilitation program available within 60 min of travel time from the patient’s home).
enominator Number of patients in an outpatient clinical practice who have had a qualifying event/diagnosis during the previous 12 months and
who do not meet any of the exclusion criteria mentioned in the Numerator section, and who have not participated in an outpatient
cardiac rehabilitation program since the qualifying event/diagnosis.
eriod of Assessment Twelve months following a qualifying event/diagnosis.
ethod of Reporting Proportion of patients in an outpatient practice who have had a qualifying event/diagnosis during the past 12 months and have
been referred to a CR program.
ources of Data Administrative data and/or medical records.
ttribution/Aggregation This measure should be reported by the clinician who provides the primary cardiovascular-related care for the patient. In general,
this would be the patient’s cardiologist, but in some cases it might be a family physician, internist, nurse practitioner, or other
health-care provider. The level of “aggregation” (clinician versus practice) will depend upon the availability of adequate sample sizes
to provide stable estimates of performance.
Rationale
ardiac rehabilitation services have been shown to help reduce morbidity and mortality in persons who have experienced a recent coronary artery disease event, but
hese services are used in less than 30% of eligible patients (19). A key component to CR utilization is the appropriate and timely referral of patients to an
utpatient CR program. While referral takes place generally while the patient is hospitalized for a qualifying event (MI, CSA, CABG, PCI, cardiac valve surgery, or
eart transplantation), there are many instances in which a patient can and should be referred from an outpatient clinical practice setting (e.g., when a patient does
ot receive such a referral while in the hospital, or when the patient fails to follow through with the referral for whatever reason).
his performance measure has been developed to help healthcare systems implement effective steps in their systems of care that will optimize the appropriate
eferral of a patient to an outpatient CR program.
his measure is designed to serve as a stand-alone measure or, preferably, to be included within other performance measurement sets that involve disease states
r other conditions for which CR services have been found to be appropriate and beneficial (e.g., following MI, CABG surgery). This performance measure is provided
n a format that is meant to allow easy and flexible inclusion into such performance measurement sets.
eferral of appropriate outpatients to a CR program is the responsibility of the healthcare provider within a healthcare system that is providing the primary
ardiovascular care to the patient in the outpatient setting.
Corresponding Guidelines and Clinical Recommendations
ee Clinical Recommendations section from Performance Measure A-1.
Challenges to Implementation
dentification all eligible patients in an outpatient clinical practice will require that a timely, accurate, and effective system be in place. Communication of referral
nformation by the outpatient clinical practice team to the outpatient CR program represents a potential challenge to the implementation of this performance
easure.
